Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A simplified prediction model for end-stage kidney disease in patients with diabetes.
Inoguchi T, Okui T, Nojiri C, Eto E, Hasuzawa N, Inoguchi Y, Ochi K, Takashi Y, Hiyama F, Nishida D, Umeda F, Yamauchi T, Kawanami D, Kobayashi K, Nomura M, Nakashima N. Inoguchi T, et al. Among authors: takashi y. Sci Rep. 2022 Jul 21;12(1):12482. doi: 10.1038/s41598-022-16451-5. Sci Rep. 2022. PMID: 35864124 Free PMC article.
Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters: Effect of denosumab on glycemic parameters.
Abe I, Ochi K, Takashi Y, Yamao Y, Ohishi H, Fujii H, Minezaki M, Sugimoto K, Kudo T, Abe M, Ohnishi Y, Mukoubara S, Kobayashi K. Abe I, et al. Among authors: takashi y. Medicine (Baltimore). 2019 Nov;98(47):e18067. doi: 10.1097/MD.0000000000018067. Medicine (Baltimore). 2019. PMID: 31764838 Free PMC article.
Clinical investigation of pituitary incidentalomas: A two-center study.
Ishii K, Abe I, Kameda W, Sugimoto K, Morinaga Y, Ito M, Takashi Y, Abe M, Hada Y, Takase K, Fujii H, Ohishi H, Ochi K, Yamao Y, Minezaki M, Kudo T, Higashi T, Sonoda Y, Ishizawa K, Kobayashi K. Ishii K, et al. Among authors: takashi y. Intractable Rare Dis Res. 2019 Nov;8(4):239-244. doi: 10.5582/irdr.2019.01083. Intractable Rare Dis Res. 2019. PMID: 31890450 Free PMC article.
Investigation of efficacy and safety of low-dose sodium glucose transporter 2 inhibitors and differences between two agents, canagliflozin and ipragliflozin, in patients with type 2 diabetes mellitus.
Sugimoto K, Abe I, Minezaki M, Takashi Y, Ochi K, Fujii H, Ohishi H, Yamao Y, Kudo T, Ohe K, Abe M, Ohnishi Y, Shinagawa T, Mukoubara S, Kobayashi K. Sugimoto K, et al. Among authors: takashi y. Drug Discov Ther. 2019;13(6):322-327. doi: 10.5582/ddt.2019.01085. Drug Discov Ther. 2019. PMID: 31956230 Free article.
Significance of Metformin Use in Diabetic Kidney Disease.
Kawanami D, Takashi Y, Tanabe M. Kawanami D, et al. Among authors: takashi y. Int J Mol Sci. 2020 Jun 14;21(12):4239. doi: 10.3390/ijms21124239. Int J Mol Sci. 2020. PMID: 32545901 Free PMC article. Review.
Renoprotective Effects of DPP-4 Inhibitors.
Kawanami D, Takashi Y, Takahashi H, Motonaga R, Tanabe M. Kawanami D, et al. Among authors: takashi y. Antioxidants (Basel). 2021 Feb 5;10(2):246. doi: 10.3390/antiox10020246. Antioxidants (Basel). 2021. PMID: 33562528 Free PMC article. Review.
77 results